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ABSTRACT:  Small interfering RNAs (siRNA) are a potentially powerful new class of 
pharmaceutical drugs for many diseases, while the delivery of unprotected siRNAs is 
ineffective due to their susceptibility to degradation by ubiquitous nucleases under 
physiological conditions. Layered double hydroxide nanoparticles (LDHs) have been 
found to be efficient carriers of anionic drugs and nucleic acids. Our previous research 
has shown that LDHs (with the Z-average particle size of approximately 110 nm) can 
mediate siRNA delivery in mammalian cells, resulting in gene silencing. However, short 
double-stranded nucleic acids are mostly adsorbed onto the external surface and not well 
protected by LDHs. In order to enhance the intercalation of siRNA into the LDH 
interlayer and the efficiency of subsequent siRNA delivery, we prepared smaller LDHs 
(with the Z-average particle size of approximately 45 nm) with an engineered non-
aqueous method. We demonstrate here that dsDNA/siRNA is more effectively 
intercalated into these small LDH nanoparticles, more dsDNA/siRNA is transfected into 
HEK 293T cells, and more efficient silencing of the target gene is achieved using smaller 
LDHs. Thus smaller LDH particles have greater potential as a delivery system for the 
application of RNA interference. 
 
Keywords:  Layered double hydroxide nanoparticles, RNA interference, Gene delivery, 
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1. Introduction 
    Gene silencing facilitated by RNA interference has proven to be a valuable tool with 
which to study gene function in the laboratory. RNA interference is mediated by small 
interfering RNAs (double-stranded RNAs, 21-23 base pairs), which are recognized by the 
cytoplasmic RNA-inducing silencing complex (RISC) and subsequently unwound. The 
single-stranded anti-sense RNA then guides RISC to the complementary target mRNA, 
resulting in its destruction [1, 2]. This targeted degradation of mRNAs has indicated that 
small interfering RNAs (siRNAs) have great potential as a new class of drugs, 
particularly in the context of monogenic diseases such as Huntington's disease where 
silencing of the mutated gene would be expected to reduce or even eliminate the gain-of-
function phenotype. 
    Systemic delivery of naked siRNA to the target tissue is ineffective due to its 
sensitivity to nuclease degradation and net negative charges which prevents interactions 
with the plasma membrane [3, 4]. Although the emergence of synthetic gene carriers has 
broadened the potential applications of siRNA therapeutics to a variety of tissue-specific 
diseases, most carriers have low biocompatability and/or inadequate delivery kinetics. 
Therefore, there is a pressing need to develop biologically compatible, synthetic 
nanoparticle-based delivery systems to protect the siRNA molecules and promote their 
cellular uptake. To date, there have been eight clinical trials involving intravenous 
injection of siRNAs encapsulated in synthetic carriers such as cationic and anionic 
liposomes, and polymeric carriers [5-7]. Proof-of-principle has come from the human 
phase I clinical trials where systemic administration of siRNA encapsulated in 
cyclodextran-based nanoparticles was found to specifically silence gene expression in 
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solid tumors [5].  
   While these studies are encouraging, there remains several challenges in the clinical 
development of siRNA nanoparticle delivery systems, such as the efficiency of cellular 
uptake, controlled and sustained release of siRNA from the carrier and enhancement in 
biocompatibility. Over recent years clay-based nanoparticles, layered double hydroxides 
(LDHs), have emerged as a siRNA delivery system with the potential to fulfill the above 
criteria. LDHs ([MgnAl(OH)2n+2]
+(A-)mH2O, where A = Cl
- or NO3
-, n = 2-3, m = 2) 
have been convincingly shown to efficiently transport a range of anionic drugs, including 
siRNAs, into mammalian cells [8-16]. Structurally, LDHs comprise alternating stacks of 
positively charged brucite-like layers ([MgnAl(OH)2n+2]
+), neutralized by exchangeable 
interlayer hydrated anions ((A-)mH2O). Thus, these nanoparticles are able to intercalate 
anionic biomolecules such as DNA and siRNAs, thereby protecting them from 
degradation [17]. LDH nanoparticles are internalized through the clathrin-mediated 
endocytosis pathway in a range of mammalian cell types, including primary neurons, 
ensuring efficient release of siRNA-LDH complexes into the cytoplasm where siRNA is 
then made available to the RISC [8, 14, 16, 18]. Our recent investigations have confirmed 
the efficacy of LDH-mediated siRNA delivery by markedly reducing the expression of 
target genes [15, 16, 19]. It has also been convincingly demonstrated that MgAl-Cl-LDH 
nanoparticles, due to their simple chemical composition, exhibit lower cytotoxicity and 
higher biocompatibility when compared to other inorganic and organic nanoparticles [16, 
20, 21]. 
    Desigaux et al. reported that linear double-stranded cDNAs (100-8000 base pairs in 
length) can be efficiently intercalated into the LDH interlayer via coprecipitation at 50-60 
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oC in the presence of excess cDNA [17]. Nakayama et al. found that heating to 80 oC 
encapsulated more cDNA (100-500 base pairs) as a result of reconstruction of calcined 
LDH [22]. These conditions, however, are inappropriate for the intercalation of short 
double-stranded RNAs (21-23 base pairs) due to their susceptibility to denaturation under 
conditions of high salt and temperature. We examined the extent of intercalation of short 
double-stranded DNAs and RNAs (23 base pairs) into MgAl-Cl-LDH nanoparticles (Z-
average diameter  = 110 nm, L-LDHs) using a non-denaturing anion exchange method. 
Under these conditions we observed suboptimal loading into the interlayer space with a 
significant proportion of the short nucleic acids adsorbed onto the LDH surface or 
partially intercalated into the interlayers [23]. This outcome highlights the need for a new 
approach to achieving maximum LDH intercalation efficiency for siRNAs under non-
denaturing conditions.  
    One potential solution to the above problem is the use of smaller LDH nanoparticles 
(S-LDHs). Their larger surface area per unit mass would be expected to increase DNA 
and siRNA intercalation efficiency. In order to decrease the LDH particle size, we 
employed an engineered non-aqueous precipitation method [24]. Therefore, the 
objectives of this study were to (i) compare the loading capacity of S-LDHs and L-LDHs, 
(ii) compare the ability of S-LDHs and L-LDHs to transport siRNA or mimic double-
stranded (ds) DNAs into HEK 293T cells, and (iii) evaluate the efficacy of siRNA-
mediated gene silencing by using S-LDHs and L-LDHs.  Our results demonstrate that S-
LDHs (Z-average particle size of approximately 45 nm) are a more efficient cellular 
delivery vehicle for siRNA compared to L-LDHs (Z-average particle size of 114 nm).   
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2. Experimental   
2.1. Preparation of LDHs 
    L-LDHs were synthesized by vigorously mixing 10 ml of aqueous solution containing 
MgCl2 (3.0 mmol) and AlCl3 (1.0 mmol) with 40 ml of NaOH solution (0.20 M) for 10 
min at room temperature. The LDH slurry was collected by centrifugation and dispersed 
in 40 ml of deionized water. The pellet was then washed twice with deionized water (40 
ml) and resuspended in deionized water (40 ml), after which the suspension was 
transferred to a Teflon-lined autoclave and hydrothermally treated at 100 °C for 16 h. 
This suspension contained approximately 4 mg/ml of homogeneously dispersed Mg3Al-
LDH nanoparticles, and characterized by photon correlation spectroscopy (PCS) and 
inductive coupled plasma atomic emission spectroscopy (ICP-AES).  
S-LDHs were prepared using a non-aqueous method. Briefly, 10 ml of methanol 
solution containing Mg(NO3)2 (6 mmol) and Al(NO3)3 (2 mmol) was added dropwise to 
40 ml methanol solution containing NaOH (16 mmol) under vigorous stirring (10 min) 
with N2 bubbling. The mixture was then transferred to a Teflon-lined autoclave, treated at 
100 °C for 16 h. After collection by centrifugation and washing twice with deionized 
water (20 ml), the slurry was resuspended in deionized water (40 ml) with the aid of 
ultrasonication (30 min), resulting in an LDH suspension containing approximately 8 
mg/ml homogeneously dispersed Mg3Al-LDH nanoparticles, as characterized by PCS 
and ICP-AES.     
 
2.2. Characterization of LDHs  
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    The LDH or LDH-DNA suspensions were examined with PCS (Nanosizer Nano ZS, 
MALVERN Instruments) to determine the particle size distribution and the Zeta potential. 
Transmission electron microscope (TEM) images of LDH nanoparticles were obtained on 
a JEOL JSM-2010 TEM at an acceleration voltage of 200 kV. Prior to TEM microscopy, 
the diluted suspension was dropped onto a copper grid coated with carbon film.   
X-ray diffraction (XRD) patterns of LDH thin films formed on a glass slide were 
collected on a Rigaku Miniflex X-ray diffractometer with variable slit width at a scanning 
rate of 2/min with 2 ranging from 5º to 80º using Co K radiation (=0.17902 nm). For 
XRD pattern collection, a few drops of LDH or siRNA/dsDNA-LDH suspension were 
placed on a clean glass slide to form an LDH thin film after drying in a 50 °C oven. 
  
2.3. Nucleic acid association with LDH 
    In some experiments dsDNA was substituted for siRNA of the same sequence to avoid 
complications arising from RNAase-mediated degradation. We have previously shown 
that the hydrodynamic diameter and zeta potential of the dsDNA-LDH and siRNA-LDH 
complexes are indistinguishable [16], demonstrating that the physicochemical properties 
of these nucleic acid-LDH complexes are equivalent at the same mass ratio of 
DNA(RNA):LDH. The association of nucleic acids into LDHs was conducted by mixing 
nucleic acids with pristine LDHs at the LDH:DNA(RNA) mass ratio of 1:1 using light 
agitation (350 rpm/min) at 37 
o
C for 30 mins.   
 
2.4. siRNAs and dsDNAs 
    Two Silencer® Pre-designed siRNAs (siRNA-DCC#1: 5’- 
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GCAAUUUGCUCAUCUCUAATT-3’ and siRNA-DCC#2: 5’-
CGAUGUAUUACUUUCGAAUTT-3’) (Ambion, TX) were derived from the mouse 
Deleted in Colorectal Carcinoma (DCC) gene [25].   
    Complementary strands of dsDNAs (HPLC purified, Geneworks, Australia) were 
annealed at 37 °C for 1 h. In some instances, both strands of the duplex were covalently 
coupled to the 6FAM fluorophore at the 5' end before anneal. The sequences of dsDNA-
DCC#1 was 5’- GCAATTTGCTCATCTCTAATT -3’, and dsDNA-DCC2# 5’- 
CGATGTATTACTTTCGAATTT -3’.  
     
2.5. Cell culture and transfection 
    Human embryonic kidney cells (HEK 293T) were cultured in L-glutamine containing 
RPMI-1640 medium (GIBCO, NY) with 10% fetal calf serum, penicillin (10 U/ml) and 
streptomycin (10 μg/ml, Gibco) in 5% CO2 at 37 °C. Cells were seeded at a density of 
5×10
5
 cells/well in 6-well plates or 1×10
4
 cells/well in 96-well plates for 24 h prior to 
exposure to the nanoparticles. For the knockdown experiment, 1 μg cDNA encoding full-
length mouse DCC [25] subcloned into the pEF/myc/cyto mammalian expression vector 
(Invitrogen) was transfected using lipofectamine 2000 according to the manufacturer’s 
instructions. Six hours later the transfection medium was replaced with fresh culture 
medium containing S-LDHs or L-LDHs intercalated with either DCC1/DCC2 (final 
concentration of siRNA = 250 nM; prepared at the mass ratio of 1:1) and cultured for a 
further 24 h incubation.   
 
2.6. MTT and proliferation assays 
 9 
    HEK 293T cells were seeded in 96-well plates at 1×10
4
 cells /well. After plating for 24 
h, cell culture medium was replaced by 100 μl fresh medium containing 0-200 μg/ml of 
S-LDHs for 48 h. In the MTT assay, 10 μl of MTT solution (5 mg/ml, Sigma, St. Louis, 
MO) was added to each well and incubated for 4 h. Medium containing MTT was then 
removed and 100 μl of dimethyl sulfoxide (Sigma) was added. Absorbance was measured 
at 530 nm. In the proliferation assay, 20 μl of CellTiter Aqueous One Proliferation Assay 
reagent (Promega, Madison, WI) was added to each well and the absorbance at 490 nm 
was measured after incubating for 2 h. A Tecan Rainbow 96 Monochromatic Microplate 
Reader (MTX Lab systems, UV, USA) was used to measure the absorbance.  
Statistics.  Each experiment was carried out in duplicate and 3 independent 
experiments were performed. The data were presented as the mean ± SEM (standard error 
of the mean). One-way ANOVA and the Dunnett's post-hoc test were used to assess 
statistical significance. **p<0.01.  
 
2.7. Flow cytometry analysis 
    siRNA/dsDNA-LDH uptake was determined by fluorescence-activated cell sorting 
(FACS). After incubation with LDH nanoparticles, HEK 293T cells were washed with 
PBS and detached using 0.05% trypsin-EDTA. The non-viable cells were excluded with 
7-aminoactinomycin D (7AAD, 20 µg/ml, Molecular Probes, OR). Extracellular 
fluorescence was quenched by treatment of 0.02% trypan blue. Flow cytometry analysis 
was undertaken on a BDTM LSR II Flow Cytometer with BD FACSDiva software. 
Fluorescence emissions from 6FAM and 7AAD were collected by 530/30 and 660/40 nm 
bandpass filter, respectively. The control cells (untreated cells and cells stained with 
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7AAD only) were used to determine the intrinsic cellular fluorescence baseline. In all 
analyses, 5,000-10,000 cells were analyzed.  
Statistics. Data were presented as the mean ± SEM. Two-way ANOVA was used to 
assess statistical significance. *p<0.05. 
 
2.8. Imaging 
    To ensure that dsDNA-DCC#1-6FAM was not associate with the cell surface, cells 
were washed with acidic medium (pH = 3.5) for 30 sec at 4 °C after incubation with 1 
µg/ml dsDNA-DCC#1-6FAM-S-LDH to remove any particles bound to the cell surface. 
Images of cells were captured on a Zeiss Axio Imager (Carl Zeiss, Germany). 
     
2.9. Western blotting 
    The extent of DCC knockdown was determined by Western blotting 24 h after 
transfection as previously described [16]. DCC was detected with anti-DCC (G97-446, 
Pharmingen San Diego, CA). The pixel density of each protein band was determined 
using Image J software, version 1.35 (National Institutes of Health, MD) and the relative 
intensity of the DCC protein band was determined by calculating the ratio of the intensity 
of the DCC band to that of the α-tubulin band (MP Biomaterials, LLC). One-way 
ANOVA and the Bonferroni post-hoc test were used to assess statistical significance. 
*p<0.05.  
 
3. Results and discussion 
3.1. Physicochemical features of S-LDHs and L-LDHs  
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     As previously described, TEM images revealed that synthesis of nanoparticles under 
aqueous conditions produced L-LDHs with a regular hexagonal shape and the lateral 
dimension ranging from 100 to 200 nm (Figure 1A and 1C) [14-16]. In contrast, the non-
aqueous conditions used to prepare S-LDHs (see Experimental) yielded hexagonally 
shaped particles with lateral dimensions ranging from 20 to 60 nm (Figure 1B and 1C). 
The Z-average diameter of S-LDHs and L-LDHs, as determined by dynamic light 
scattering, was 45 and 114 nm, respectively, with a similar polydispersity (Pdi: 0.19 vs. 
0.22) (Figure 1C and Table 1). The zeta potential for the small pristine nanoparticles (S-
LDHs) was ~ 45 mV (Table 1). Similarly, pristine L-LDHs have an average zeta potential 
of ~43-48 mV [16, 23], indicating that their surface charge density is equivalent.  
 
                              (A)                                                                    (B) 
                 
 
                                      (C) 
 
 
Figure 1.  TEM images of pristine LDH nanoparticles: (A) L-LDHs and (B) S-
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LDHs. (C) Particle size distribution of pristine S-LDHs and L-LDHs. 
Figure 2 shows the XRD patterns of as-prepared large and small LDHs. As the 
measurements were conducted using an in situ-formed thin film (i.e. most LDH plates 
were laid flatly on the glass substrate), only the basal diffractions, such as (003), (006) 
and (009), were detected. Both nanoparticles displayed a layered structure, with a d-
spacing of 0.785 nm for L-LDHs and 0.819 nm for S-LDHs. The former value is very 
close to that reported for MgAl-Cl-LDH [26], while the latter is a slightly larger than that 
for Mg3Al-OH-LDH, probably due to intercalation of some methoxide [27]. However, the 
L-LDH diffraction pattern was stronger and sharper than that produced by S-LDHs, 
indicating that L-LDHs have better crystallinity. The crystal thickness along the c-axis 
was estimated (by substituting the full width at the half maximum (FWHM) of peak (003) 
into the Scherrer’s Equation) to be approx. 20 nm for L-LDHs and approx. 5 nm for S-
LDHs, indicating that S-LDHs comprised four-fold fewer interlayer sheets than L-LDHs.     
 
Figure 2. XRD patterns of S-LDH and L-LDH before and after dsDNA loading. The 
dsDNA-S-LDH and dsDNA-L-LDH complexes were formed by mixing LDH 
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nanoparticle suspensions with dsDNA at 37 oC for 1 h at a dsDNA:LDH mass ratio of 
1:1. 
 
3.2. Association of dsDNA with LDHs 
XRD analysis was also performed on S-LDHs and L-LDHs after association of dsDNA 
at 37 oC for 2 h at the mass ratio of dsDNA:LDH = 1:1. Interestingly, in the case of S-
LDHs, the basal diffractions at (003) and (006) were markedly reduced after dsDNA 
association, e.g. the stacking of the hydroxide layers was largely distorted, which could 
be attributed to extensive dsDNA intercalation into the LDH interlayer, at least in the 
near-edge interlayer region. On the other hand, the XRD patterns of L-LDHs before and 
after dsDNA loading were very similar, indicating that the dsDNA had less effectively 
penetrated into the L-LDH interlayer, as reported previously [23]. Therefore, the changes 
in the XRD pattern provide indirect evidence that short double-stranded nucleic acids 
intercalate more efficiently into the interlayer of S-LDHs compared to L-LDHs, which is 
supported by the loading amount what does this mean????, as presented in the following 
paragraphs.  
 
Table 1:   Physicochemical characteristics of LDH and LDH complexes 
 Z-average size (nm) Polydispersity (Pdi) Zeta potential (mV) 
Pristine S-LDH 454 0.150.02 40.42.0 
dsDNA-S-LDH (1:1) 11410 0.550.10 -28.25.0 
Pristine L-LDH 1145 0.220.03 43.32.0 
dsDNA-L-LDH (1:1) 14910 0.500.10 -36.74.0 
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Table 1 shows the Z-average particle size and zeta potential of pristine S-LDHs and 
dsDNA-S-LDH complexes at the dsDNA:S-LDH mass ratio of 1:1. The dsDNA-S-LDH 
complexes had an average particle size of 114 nm and a Pdi of 0.55, both larger than 
those of pristine S-LDHs (45 nm and 0.15), indicating that the complexes were slightly 
aggregated, with a much broad particle size distribution. This is similar to the case of 
dsDNA-L-LDHs whose Z-average particle size and Pdi were 149 nm and 0.50, 
respectively, in comparison with 114 nm and 0.22 of pristine L-LDHs [23]. In addition, 
both dsDNA-S-LDHs and dsDNA-L-LDHs were negatively charged, with the zeta 
potential being -28.2 and -36.7 mV, respectively, reflecting that dsDNA was extensively 
surface adsorbed, and that the surface adsorption of dsDNA was a bit more on L-LDHs.   
As the LDH particle size decreases, the exposed specific surface area increases 
proportionally. Therefore, S-LDHs would be expected to have enhanced surface 
adsorption of dsDNA/siRNA, which would facilitate their intercalation. Such an effect 
has previously been reported in the context of anionic dye (300-500 Dalton)-LDH 
interactions [28]. In their study, Roeffaers and colleagues showed that surface adsorption 
occurred first and was required for subsequent insertion of the dye into the interlayer.  
This implies that in the case of a smaller particle, the same surface association of 
dsDNA/siRNA would result in a higher degree of intercalation than in a larger particle 
given the interactions between the brucite-like layers and the interlayer anions are similar. 
As the XRD analysis of dsDNA-S-LDHs showed that the basal diffractions at (003) and 
(006) were markedly reduced compared to those generated from pristine S-LDHs, the 
stacking of the hydroxide layers could be severely disrupted as a result of a higher degree 
of dsDNA intercalation. In contrast, there was little difference in the XRD patterns of L-
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LDHs before and after dsDNA loading, implying intercalation of dsDNA/siRNA into the 
interlayer was minimal [23]. As already discussed in our previous paper [23], the dsDNA 
loading on L-LDHs was 0.2-0.3 µg (dsDNA)/µg (L-LDHs) at the mass ratio of 1:1, 
where the dsDNA was largely associated with the LDH particle surface. For S-LDHs (45 
nm), we would estimate that the loading of dsDNA was 0.4-0.5 µg (dsDNA)/µg (S-
LDHs) at the same mass ratio under the same conditions. Consequently, the intercalation 
of dsDNA into the S-LDH interlayers would be double that predicted for the L-LDH 
interlayers if we assume that intercalation is proportional to the surface-adsorbed amount. 
Therefore, we conclude that the reduction in LDH size greatly facilitates the loading of 
short double-stranded nucleic acids, thereby allowing less stringent anion exchange 
conditions to be employed for siRNA adsorption/intercalation.  
(A) (B) 
 
       
 
Figure 3. (A) MTT assay and (B) Proliferation assay after incubation of HEK 293T cells 
with pristine S-LDHs for 48 h.   
 
3.3. S-LDHs have low cytotoxicity 
    Small LDH nanoparticles have been reported to be more cytotoxic due to their 
increased surface area per unit mass [20, 29]. Therefore, we determined the cytotoxicity 
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of S-LDHs in HEK 293T cells exposed to pristine S-LDHs (0-200 μg/ml) for 48 h after 
which their viability was assessed using the MTT assay (Figure 3A). We observed no 
significant loss of cell viability across this concentration range. This is consistent with 
our previous observations that at an L-LDH concentration of up to 500 μg/ml cell 
viability was found to be greater than 80-90% in various cell lines [12, 15, 30, 31]. As a 
second measure of cell viability, we investigated the effect of S-LDHs on the ability of 
HEK 293T cells to proliferate after 48 h exposure (Figure 3B). At 12.5 μg/ml of S-LDHs 
the proliferation rate was indistinguishable from that of control cultures, whereas the 
proliferation decreased to 81% at 25 μg/ml. At high concentrations (100-200 μg/ml) only 
62% cells were able to proliferate. Previously, we reported that the proliferation rate was 
70-80 % at 25 μg/ml L-LDHs for HEK 293T cells [15, 31]. Together these data show 
that, like L-LDHs (110 nm), S-LDHs (45 nm) have negligible cytotoxicity at low, 
biologically relevant concentrations (i.e. up to 25 μg/ml).  Therefore, the concentrations 
of siRNA/dsDNA and LDH at no more than 10 μg/ml (1:1 mass ratio) used in subsequent 
experiments ensure the minimal disturbance of cell viability and proliferation.   
                                           (A)                                                           (B) 
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Figure 4.  LDHs facilitated uptake of fluorencently tagged dsDNA into HEK 293T cells. 
(A) Microcopy imaging of 6FAM (green fluorescent puncta) of cells after 4 h exposure to 
1.0 g/ml dsDNA, dsDNA:LDH = 1:1. (B) The uptake of dsDNA-DCC-6FAM-S-LDH 
complexes (0.1, 1 and 10 g/ml dsDNA; dsDNA:LDH = 1:1) was observed after 4 h 
incubation of HEK 293T cells.   
 
3.4. dsDNA-S-LDH complexes are efficiently internalized by HEK 293T cells 
    Light-microscopic imaging of HEK 293T cells showed significantly brighter 6FAM-
positive puncta within the cytoplasm after exposure to dsDNA-6FAM-S-LDH than to 
dsDNA-6FAM-L-LDH complexes (10 μg/ml of dsDNA, dsDNA:S-LDH = 1:1, 4 h) 
(Figure 4A), confirming that S-LDH nanoparticles are more efficiently internalized by 
HEK 293T cells. These puncta are likely to be early endosomes and multivesicular 
bodies, which we have previously shown to be the internalization route for L-LDHs [13, 
14, 16]. No fluorescence was observed in cells incubated with dsDNA-6FAM alone (first 
row in Figure 4A).  
    We next examined the efficiency of S-LDH- and L-LDH-mediated dsDNA uptake into 
HEK 239T cells by flow cytometry (FACS). In these experiments both strands of the 
dsDNAs were labeled with the 6FAM fluorophore. Cells were exposed to 0.1, 1 or 10 
μg/ml of dsDNA-6FAM associated with S-LDHs or L-LDHs (mass ratio 1:1, i.e. 0.1, 1 or 
10 μg/ml of S-LDHs or L-LDHs) for 4 h, after which the percentage of 6FAM-positive 
cells was assessed. The cytoplasmic fluorescence of cells exposed to dsDNA alone was 
equivalent to the intrinsic background fluorescence of the untreated cells (data not 
shown). When exposed to dsDNA-6FAM-S-LDH and dsDNA-6FAM-L-LDH at a 
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dsDNA concentration of 10 μg/ml, 88% and 58% of cells were 6FAM-positive, 
respectively (Figure 4B and Table 2). Moreover, the extent of internalization for 
individual cells was markedly greater for the S-LDH complexes at this dsDNA 
concentration. The median fluorescence intensity (FI) for the population exposed to the 
S-LDH complexes was 2.9 FI units, while only 1.6 FI units for cells exposed to the L-
LDH complexes (Table 2). Therefore, S-LDH-mediated dsDNA internalization was 
nearly 2-fold more efficient than L-LDH-mediated internalization.  
     
Table 2 
 
 
    This difference in S-LDH and L-LDH uptake efficiency was also observed at a dsDNA 
concentration of 1 μg/ml (Figure 4B and Table 2). In this case 4% of cells were 6FAM-
positive after exposure to the S-LDH complexes and the median FI for the population 
was 1.9, whereas only 0.5% of cells internalizing the L-LDH complexes and the median 
FI was 1.7.  As previously observed [16], very few cells were found to be 6FAM-positive 
when using a dsDNA concentration of 0.1 μg/ml with either S-LDHs or L-LDHs (Table 
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2). Taken together, the above results clearly demonstrate that the smaller LDH 
nanoparticles are able to more effectively transport short double-stranded nucleic acids 
into HEK 293T cells. The higher efficiency can be largely attributed to the higher loading 
of dsDNA on S-LDHs. The second reason could be the smaller particle size as Oh et al 
has also reported that small LDHs were a more effective transport vehicle for 
MNNG/HOS cells [8]. 
  
3.5. Gene silencing using LDH-mediated delivery of siRNA 
    Our previous study demonstrated that L-LDH-mediated siRNA delivery results in 
gene-specific silencing in HEK 293T cells and cultured neurons [15, 16]. To compare the 
effectiveness of RNA interference after delivery using S-LDHs and L-LDHs, we targeted 
the neuronal gene DCC [25], and used the mass ratios of 1:1 to prepare the siRNA-LDH 
complexes. HEK 293T cells were first transfected with the DCC expression plasmid. Six 
hours later the transfection medium was replaced with fresh culture medium containing 
control siRNA- or DCC siRNA-LDH complexes (final concentration of siRNA = 250 
nM, i.e. 3.25 µg/ml) for a further 24 h. Cell lysates were then subjected to Western 
blotting using an antibody specific for the DCC protein and an anti-α-tubulin antibody as 
the loading control (Figure 5A). DCC protein levels were quantified relative to α-tubulin 
levels using densitometry. The extent of knockdown was then calculated as the 
percentage of DCC protein relative to that in untreated cells.  As shown in Figure 5B, 
substantial knockdown of DCC expression was seen after incubation with siRNA-DCC-
S-LDH (43% knockdown), whereas approx. 20% knockdown was achieved using L-
LDHs at this mass ratio. Significantly higher S-LDH-mediated knockdown of DCC can 
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be attributed to the following factors: (1) more siRNA was associated with S-LDHs due 
to greater surface adsorption and subsequent intercalation; (2) S-LDHs were a more 
efficient vehicle for dsDNA/siRNA cellular delivery (Figure 4B) [8]; and (3) dsDNA-S-
LDH complexes were less negatively charged leading to smaller aggregates (-28.2 mV 
and 114 nm, Table 1) compared to dsDNA-S-LDH complexes (-36.7 mV and 149 nm, 
Table 1). Therefore, we conclude that S-LDHs are a better vehicle for siRNAs delivery.  
 
                                    (A)                                                           (B) 
 
         
 
Figure 5. Knockdown of DCC using S-LDH and L-LDH mediated delivery of siRNA to 
HEK 293T cells. (A) Western blotting image of cell lysates using anti-DCC and anti-α-
tubulin antibodies. (B) The DCC to α-tubulin ratio of relative intensity, normalized to the 
untreated control. Data were presented as the mean ± SEM. *p < 0.05. KD: percentage of 
DCC knockdown.   
 
4. Conclusions 
    In this study we developed a non-denaturing anion exchange protocol which permitted 
high capacity intercalation of functional siRNAs into small LDH nanoparticles (S-LDHs, 
 21 
45 nm), whereas the extent of intercalation into L-LDH (114 nm) interlayers under the 
same conditions was much reduced. Our investigation of the physicochemical properties 
of S-LDHs suggests that the enhanced S-LDH loading capacity was due to an increase in 
both the high specific surface area. Although both S-LDHs and L-LDHs transported short 
double-stranded nucleic acids into HEK 293T cells effectively, S-LDH-mediated 
internalization was considerably more efficient at the mass ratio of 1:1. Importantly, S-
LDH-mediated siRNA delivery resulted in more extensive targeted gene silencing 
compared to L-LDH-mediated. In addition, reduction in LDH particles size did not affect 
cell viability at a concentration up to 200 μg/ml, and proliferative ability was not 
disturbed at biologically relevant concentrations (25 μg/ml or less). Therefore, smaller 
LDH particles will have greater potential as a drug delivery system for the application of 
RNA interference. 
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